Back to search

Article

Cordycepin derived from engineered Pichia pastoris inhibits fibrosarcoma HT1080 cells by targeting Akt1 and kinase activity

2025-01-17

Abstract excerpt

Fibrosarcoma cells exhibit low sensitivity to chemotherapy and significant drug resistance, emphasizing the urgent need for effective, low-toxicity therapeutic agents with reliable production methods and novel treatment strategies. Cordycepin (3’-deoxyadenosine) has shown promising therapeutic potential in cancer treatment. In this study, cordycepin was produced using a genetically engineered Pichia pastoris stra...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f0eccc5a-f2a0-552d-8744-8b4f920d4615
DOI
10.22541/au.173710998.89396227/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cordycepin derived from engineered Pichia pastoris inhibits fibrosarcoma HT1080 cells by targeting Akt1 and kinase activityDOI 10.22541/au.173710998.89396227/v1
Select a neighboring publication to make it the new centre.